- Home
- CELZ vs ENSC Comparison
CELZ vs ENSC Comparison
Compare CELZ & ENSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CELZ
- ENSC
- Stock Information
- Founded
- CELZ 1998
- ENSC 2003
- Country
- CELZ United States
- ENSC United States
- Employees
- CELZ N/A
- ENSC N/A
- Industry
- CELZ Biotechnology: Pharmaceutical Preparations
- ENSC Biotechnology: Pharmaceutical Preparations
- Sector
- CELZ Health Care
- ENSC Health Care
- Exchange
- CELZ Nasdaq
- ENSC Nasdaq
- Market Cap
- CELZ 5.5M
- ENSC 5.5M
- IPO Year
- CELZ N/A
- ENSC N/A
- Fundamental
- Price
- CELZ $2.29
- ENSC $2.44
- Analyst Decision
- CELZ
- ENSC
- Analyst Count
- CELZ 0
- ENSC 0
- Target Price
- CELZ N/A
- ENSC N/A
- AVG Volume (30 Days)
- CELZ 140.2K
- ENSC 24.9K
- Earning Date
- CELZ 05-09-2025
- ENSC 05-12-2025
- Dividend Yield
- CELZ N/A
- ENSC N/A
- EPS Growth
- CELZ N/A
- ENSC N/A
- EPS
- CELZ N/A
- ENSC N/A
- Revenue
- CELZ $11,000.00
- ENSC $5,210,031.00
- Revenue This Year
- CELZ N/A
- ENSC N/A
- Revenue Next Year
- CELZ N/A
- ENSC N/A
- P/E Ratio
- CELZ N/A
- ENSC N/A
- Revenue Growth
- CELZ 22.22
- ENSC 133.58
- 52 Week Low
- CELZ $1.92
- ENSC $2.12
- 52 Week High
- CELZ $6.90
- ENSC $14.67
- Technical
- Relative Strength Index (RSI)
- CELZ 32.75
- ENSC 22.16
- Support Level
- CELZ $1.95
- ENSC $2.19
- Resistance Level
- CELZ $2.24
- ENSC $2.70
- Average True Range (ATR)
- CELZ 0.33
- ENSC 0.30
- MACD
- CELZ -0.07
- ENSC -0.04
- Stochastic Oscillator
- CELZ 5.63
- ENSC 17.07
About CELZ Creative Medical Technology Holdings Inc.
Creative Medical Technology Holdings Inc is a biotechnology holding company focused on regenerative medicine. It is formed for the purpose of creating and licensing intellectual property in the area of amniotic fluid derived stem cells for therapeutic applications. Its core activity is stem cell research and the development of applications for use to treat male and female sexual dysfunction, infertility, miscarriages, and related issues.
About ENSC Ensysce Biosciences Inc.
Ensysce Biosciences Inc is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs. The company is developing a new class of powerful, tamper-proof opioids that prevent both drug abuse and overdoses. Its products are anticipated to provide safer options to treat severe pain and assist in preventing deaths caused by opioid abuse, reducing human and economic costs. The company's current development pipeline includes two new drug platforms: an abuse-resistant opioid prodrug technology, theTrypsin Activated Abuse Protection, or the TAAP platform, and an over-dose protection opioid prodrug technology, the Multi-Pill Abuse Resistant, or the MPAR platform. The Company currently operates in one business segment, which is pharmaceuticals.